➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Johnson and Johnson
Medtronic
Dow
Boehringer Ingelheim

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 5,861,277

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,861,277
Title: Methods and compositions for enhancing the expression of genes in plants
Abstract:Disclosed are methods of increasing exogenous protein expression in a cell or a transgenic plant. Constructs, i.e., vectors, DNA fusions and polynucleotides, for use in conjunction with the methods to cause increased exogenous protein expression are also disclosed. These constructs generally include intron 1 and/or intron 2 of the PAT1 gene. Additionally disclosed are cells, including recombinant cells, and plant lines transformed with the described constructs. In particular, a cultivated, transgenic food plant, the genome of which has been augmented through the genomic introduction of a preselected exogenous protein gene not found in the genome of non-transformed parentage of the plant is described. Also described are seed, progeny and cells of the described transgenic food plant.
Inventor(s): Rose; Alan B. (Davis, CA), Last; Robert L. (Ithaca, NY)
Assignee: Boyce Thompson Institute for Plant Research, Inc. (Ithaca, NY)
Application Number:08/723,624
Patent Claims:see list of patent claims

Details for Patent 5,861,277

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Boyce Thompson Institute for Plant Research, Inc. (Ithaca, NY) 2039-02-26 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Boyce Thompson Institute for Plant Research, Inc. (Ithaca, NY) 2039-02-26 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Boyce Thompson Institute for Plant Research, Inc. (Ithaca, NY) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
AstraZeneca
Boehringer Ingelheim
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.